Abstract.
Portal vein resection during pancreaticoduodenectomy has recently experienced renewed interest. We describe our results with this procedure over a 20-year period. Among 88 consecutive pancreatectomies for cancer of head of the pancreas, 14 included en bloc removal of the portal vein. There was no hospital mortality. Only 21% were found to have histologically confirmed cancer invasion, and the remainder had inflammatory adherence. Two-year survival was 15% compared to 34% for patients who did not have portal vein resection. There were no 5-year survivors. We discuss our results in light of other recent reports.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Launois, B., Stasik, C., Bardaxoglou, E. et al. Who Benefits from Portal Vein Resection during Pancreaticoduodenectomy for Pancreatic Cancer?. World J. Surg. 23, 926–929 (1999). https://doi.org/10.1007/s002689900601
Issue Date:
DOI: https://doi.org/10.1007/s002689900601